Related Experiment Videos
Failure To detect muramic acid in normal rat tissues but detection in cerebrospinal fluids from patients with
M P Kozar1, M T Krahmer, A Fox
1Department of Microbiology and Immunology, University of South Carolina School of Medicine, Columbia, South Carolina, USA.
Abstract:
Muramic acid serves as a marker for the presence of bacterial cell wall debris in mammalian tissues. There have been a number of controversial and sometimes conflicting results on assessing the levels of muramic acid in health and disease. The present report is the first to use the state-of-the art technique, gas chromatography-tandem mass spectrometry, to identify and quantify the levels of muramic acid in tissues. Muramic acid was not found in normal rat brain or spleen. However, when tissues were spiked with muramic acid, it was readily identified. The detection limit was <1 ng of muramic acid/100 mg (wet weight) of tissue. The levels of muramic acid reported in diseased human spleen and spleen of arthritic rats, previously injected with bacterial cell walls, were 100- to 1,000-fold higher. In the present study, muramic acid was also readily detected in the cerebrospinal fluid of patients with pneumococcal meningitis (6.8 to 3,900 ng of muramic acid/ml of cerebrospinal fluid). In summary, there can be an enormous difference in the levels of muramic acid found in different mammalian tissues and body fluids in health and disease. This report could have great impact in future studies assessing the role of bacterial cell wall remnants in the pathogenesis of certain human inflammatory diseases.
Insights
Muramic acid, a bacterial cell wall marker, was undetectable in normal rat tissues but found in diseased human and rat samples. This study establishes a sensitive method for its detection, impacting inflammatory disease research.
Area of Science:
- Biochemistry
- Microbiology
- Pathology
Background:
- Muramic acid is a key component of bacterial cell walls.
- Previous studies on muramic acid levels in mammalian tissues yielded conflicting results.
- Accurate quantification of muramic acid is crucial for understanding its role in disease.
Purpose of the Study:
- To establish a sensitive and reliable method for identifying and quantifying muramic acid in mammalian tissues and body fluids.
- To investigate the presence and levels of muramic acid in normal and diseased states.
- To assess the potential of muramic acid as a biomarker in inflammatory diseases.
Main Methods:
- Gas chromatography-tandem mass spectrometry (GC-MS/MS) was employed for sensitive detection and quantification.
- Analysis of normal rat brain and spleen tissues.
- Analysis of spiked tissue samples to determine detection limits.
- Analysis of cerebrospinal fluid from patients with pneumococcal meningitis.
- Analysis of spleen tissues from arthritic rats previously exposed to bacterial cell walls.
Main Results:
- Muramic acid was not detected in normal rat brain or spleen tissues.
- The detection limit of the GC-MS/MS method was established at <1 ng/100 mg tissue.
- Significantly elevated levels of muramic acid (100- to 1,000-fold higher) were found in diseased human spleen and arthritic rat spleen.
- Muramic acid was readily detected in cerebrospinal fluid of patients with pneumococcal meningitis, ranging from 6.8 to 3,900 ng/ml.
Conclusions:
- Gas chromatography-tandem mass spectrometry provides a highly sensitive method for muramic acid detection.
- Muramic acid is present at significantly elevated levels in specific disease states, particularly those involving bacterial infections or inflammation.
- This methodology and findings have significant implications for future research into the role of bacterial cell wall remnants in human inflammatory diseases.